Nektar Therapeutics (NKTR) Shareholder's Equity Growth (1y) (2011 - 2026)
Nektar Therapeutics (NKTR) Shareholder's Equity Growth (1y) (2011 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Nektar Therapeutics |
1.51 Bn |
939.55 Mn |
3.16 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
4,094.32% |
| Dec 31, 2025 |
47.90% |
| Sep 30, 2025 |
74.06% |
| Jun 30, 2025 |
-130.38% |
| Mar 31, 2025 |
-89.16% |
| Dec 31, 2024 |
-53.63% |
| Sep 30, 2024 |
-69.33% |
| Jun 30, 2024 |
-59.54% |
| Mar 31, 2024 |
-47.40% |
| Dec 31, 2023 |
-64.27% |
| Sep 30, 2023 |
-61.34% |
| Jun 30, 2023 |
-57.06% |
| Mar 31, 2023 |
-60.38% |
| Dec 31, 2022 |
-46.04% |
| Sep 30, 2022 |
-48.57% |
| Jun 30, 2022 |
-49.31% |
| Mar 31, 2022 |
-38.88% |
| Dec 31, 2021 |
-36.92% |
| Sep 30, 2021 |
-31.55% |
| Jun 30, 2021 |
-27.96% |
